AN2 Therapeutics, Inc.
Developing novel small molecule drugs for infectious diseases and oncology using boron chemistry.
ANTX | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 1800 EL CAMINO REAL, SUITE D, 94027 MENLO PARK
- Website:
- https://www.an2therapeutics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics. The company leverages its proprietary boron chemistry platform to create a pipeline of compounds aimed at delivering first-in-class or best-in-class treatments. Its primary mission is to develop therapies for rare, chronic, and serious infectious diseases with high unmet medical needs, with an additional focus on oncology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all AN2 Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AN2 Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AN2 Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
